Identifying CEACAM1-targeted Drug Candidates for Cancer Immunotherapy

Carcinoembryonic antigen-related cell adhesion molecule 1 (CEACAM1) is a key regulatory protein in immune modulation and tumor progression, making it a promising target for cancer immunotherapy. Immunotherapy is promising because it harnesses the body's own immune system to identify and eliminate cancer cells, o

Authors

Guanrong Cheng

Publication Details

Journal: European Journal of Biomedical and Life Sciences
Published: 2024-10-31
DOI: https://doi.org/10.29013/ejbls-24-3-21-38
Primary Topic: Radiopharmaceutical Chemistry and Applications
Type: article
Field-Weighted Citation Impact: 0.00

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

Identifying CEACAM1-targeted Drug Candidates for Cancer Immunotherapy

Guanrong Cheng

Oct 31, 2024

European Journal of Biomedical and Life Sciences

Radiopharmaceutical Chemistry and Applications

article

Identifying CEACAM1-targeted Drug Candidates for Cancer Immunotherapy

Guanrong Cheng

October 31, 2024article en

Abstract

European Journal of Biomedical and Life Sciences

Good health and well-being

Openalex Percentile: Top 68%

Radiopharmaceutical Chemistry and Applications

DOI Open Access PDF OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Identifying CEACAM1-targeted Drug Candidates for Cancer Immunotherapy — Guanrong Cheng · European Journal of Biomedical and Life Sciences (2024) | TGRS Research Map | TGRS